연구성과로 돌아가기
2021 연구성과별 연구자 정보 (742 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Doerffel, Yvonne | Doerffel, Y | 13 | Charite, Berlin, Germany | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Forman, Lisa | Forman, L | 14 | Univ Colorado, Aurora, CO USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Freilich, Bradley | Freilich, B | 15 | Kansas City Res Inst, Kansas City, KS USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Gheorghe, Liana | Gheorghe, L | 16 | Fundeni Clin Inst, Bucharest, Romania | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Gonzalez, Maria Sarai | González, MS | 17 | Consultorio Doctora Maria Sarai Gonzalez Huezo, Metepec, Mexico | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Harrison, Stephen | Harrison, S | 18 | Pinnacle Clin Res, San Antonio, TX USA | GON-3283-2022 | Harrison, Stephen | ychoi@cymabay.com; | |||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Huang, Jonathan | Huang, J | 19 | Univ Rochester, Rochester, NY 14627 USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Jeong, Sook-Hyang | Jeong, SH | 20 | Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea | J-5642-2012 | Jeong, Sook-Hyang | ychoi@cymabay.com; | |||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Kim, Seung Up | Kim, SU | 21 | Yonsei Univ Hlth Syst, Severance Hosp, Seoul, South Korea | L-4239-2013 | Kim, Sun | ychoi@cymabay.com; | |||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Lake, John | Lake, J | 22 | Univ Minnesota, Minneapolis, MN USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Odin, Joseph | Odin, J | 23 | Mt Sinai Hosp, New York, NY 10029 USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Tak, Won Young | Tak, WY | 24 | Kyungpook Natl Univ Hosp, Daegu, South Korea | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Tobias, Hillel | Tobias, H | 25 | Concorde Med Grp, New York, NY USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Vierling, John M. | Vierling, JM | 26 | Baylor Coll Med, Houston, TX 77030 USA | ychoi@cymabay.com; | |||||
| Efficacy, safety, and tolerability of seladelpar in patients with compensated liver cirrhosis due to primary biliary cholangitis (PBC): a pooled analysis of phase 2 and phase 3 studies | Yang, Ke | Yang, K | 27 | CymaBay Therapeut, Newark, CA USA | ychoi@cymabay.com; |
페이지 이동: